Russell Investments Group
LRMR icon

Russell Investments Group’s Larimar Therapeutics LRMR Stock Holding History

Russell Investments Group’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83.5K Buy
27,364
+23,775
+662% +$94.4K ﹤0.01% 3502
2026
Q1 		$16.2K Sell
3,589
-2,328
-39% -$9.3K ﹤0.01% 3675
2025
Q4 		$22.5K Buy
5,917
+1,069
+22% +$4.16K ﹤0.01% 3588
2025
Q3 		$15.7K Buy
4,848
+4,734
+4,153% +$17.8K ﹤0.01% 3667
2025
Q2 		$329 Sell
114
-79
-41% -$183 ﹤0.01% 3773
2025
Q1 		$415 Buy
+193
New +$610 ﹤0.01% 3690
2024
Q3 		– Sell
-1,755
Closed -$12.7K – 3747
2024
Q2 		$12.7K Buy
+1,755
New +$13.4K ﹤0.01% 3028
2021
Q2 		– Sell
-13,163
Closed -$192K – 3264
2021
Q1 		$192K Hold
13,163
– – ﹤0.01% 2844
2020
Q4 		$281K Hold
13,163
– – ﹤0.01% 2650
2020
Q3 		$199K Hold
13,163
– – ﹤0.01% 2778
2020
Q2 		$169K Sell
13,163
-8,607
-40% -$100K ﹤0.01% 2755
2020
Q1 		$201K Sell
21,770
-11,179
-34% -$147K ﹤0.01% 2554
2019
Q4 		$438K Buy
32,949
+15,489
+89% +$148K ﹤0.01% 2454
2019
Q3 		$155K Buy
+17,460
New +$191K ﹤0.01% 2693
2018
Q4 		– Sell
-42
Closed -$6K – 2991
2018
Q3 		$6K Hold
42
– – ﹤0.01% 2933
2018
Q2 		$5K Buy
+42
New +$3.57K ﹤0.01% 2889
2018
Q1 		– Sell
-1,762
Closed -$100K – 2955
2017
Q4 		$100K Buy
1,762
+234
+15% +$10.5K ﹤0.01% 2775
2017
Q3 		$65K Buy
1,528
+661
+76% +$27.5K ﹤0.01% 2826
2017
Q2 		$37K Buy
867
+576
+198% +$29.5K ﹤0.01% 2908
2017
Q1 		$16K Sell
291
-501
-63% -$24.9K ﹤0.01% 2958
2016
Q4 		$31K Buy
+792
New +$32.1K ﹤0.01% 3012

Other funds holding LRMR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CSP
Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return
WG
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
NLP
Next Level Private Harrison, New York $511M AUM 30.94% 1-Year Est. Return

Russell Investments Group's LRMR Position: Q2 2026 in Review

Russell Investments Group increased its Larimar Therapeutics (LRMR) stake by 662% in Q2 2026, buying an estimated $94.4K and bringing the position to 27,364 shares worth $83.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3502.

Russell Investments Group first reported a position in LRMR in Q4 2016 and has held it in 21 quarters since. The position peaked at $438K in Q4 2019. 46 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • Russell Investments Group held 27,364 shares of Larimar Therapeutics worth $83.5K as of Q2 2026.
  • Russell Investments Group bought 23,775 Larimar Therapeutics shares in Q2 2026, an estimated $94.4K.
  • Larimar Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3502 holding.
  • Russell Investments Group first reported a position in Larimar Therapeutics in Q4 2016 and has held it in 21 quarters since.
  • Russell Investments Group's Larimar Therapeutics position peaked at $438K in Q4 2019.
  • 46 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.